Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC6A7 encodes a high-affinity sodium- and chloride-dependent L-proline transporter protein. This transporter is primarily responsible for the active uptake of L-proline into neurons, regulating levels of this amino acid at excitatory synapses. Its activity influences excitatory neurotransmission; alterations or dysfunctions could impact neurological processes or diseases involving glutamatergic signaling or amino acid metabolism. Enkephalins can competitively inhibit PROT/SLC6A7, suggesting potential cross-talk between opioid peptides and proline-mediated signaling pathways in the CNS.
Competitive inhibition of L-proline transport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 6 member 7 (SLC6A7).